Family genetic screening methods for heart rhythm risk
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study compares two ways to find relatives who may carry a specific inherited genetic change. It may help your family learn faster who should get follow-up testing and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You (the person being tested) carry either the KCNQ1 Thr224Met change or the APOB R3527Q change
- You have a first-degree relative (parent, child, or sibling) of that person
- Your first-degree relative is also part of the family being screened
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is about helping families with familial hypercholesterolemia (a genetic condition that causes very high cholesterol) get screened. It tests a way to reach close relatives so they can learn their risk and consider next steps.
This study is building a database to better understand how different changes in the KCNH2 gene affect health. It may help doctors make more accurate diagnoses and predictions for people with this gene variant.
This study uses a 'cascade testing' approach, where family members of people with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol, are tested to see if they also have it. The goal is to identify and test at-risk relatives early so they can get treatment to prevent heart problems.
This study looks at how physical activity and exercise capacity affect people with a heart rhythm condition called congenital long QT syndrome. It may help you understand safe ways to stay active and improve your heart health.
This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.
This study looks at how proteins that connect heart cells are distributed in people with inherited heart rhythm disorders (and some family members who may carry the gene). It aims to better understand the biology behind these conditions, which may help improve risk assessment and future care.
Hear when a new Long QT Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.